No abstract available
MeSH terms
-
Adolescent
-
Adult
-
Cost-Benefit Analysis
-
Disease Transmission, Infectious / prevention & control
-
Female
-
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
-
Humans
-
Male
-
Papillomavirus Infections / economics
-
Papillomavirus Infections / prevention & control*
-
Papillomavirus Infections / transmission
-
Papillomavirus Vaccines / economics*
-
Sexually Transmitted Diseases, Viral / prevention & control*
-
United States
-
Uterine Cervical Neoplasms / prevention & control
-
Young Adult
Substances
-
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
-
Papillomavirus Vaccines